Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 2/20 | 0.31 |
| ▸ | PROKR1 | Q8TCW9 | 3/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25772254 | 0.90 | MRGPRX4 (0.35) | MRGPRX4SMN1; SMN2MAPTLMNAGAA | |
| SCHEMBL25772697 | 0.89 | KMT2A (0.34) | MAPTKMT2AKCNH2THRB | |
| SCHEMBL25772194 | 0.86 | RORC (0.38) | MRGPRX4SMN1; SMN2MAPTLMNAGAA | |
| SCHEMBL25781025 | 0.85 | KMT2A (0.35) | SMN1; SMN2MAPTLMNAKMT2ATHRB | |
| SCHEMBL25781329 | 0.82 | KMT2A (0.35) | MAPTKMT2AKCNH2THRB | |
| SCHEMBL25781205 | 0.78 | CYP4F2 (0.39) | MAPTLMNAKMT2AKCNH2 | |
| SCHEMBL25781416 | 0.76 | ADRB3 (0.34) | MAPTKMT2AKCNH2 | |
| SCHEMBL25777386 | 0.75 | OXER1 (0.51) | MRGPRX4 | |
| SCHEMBL25772253 | 0.74 | RORC (0.40) | MRGPRX4SMN1; SMN2MAPTLMNAGAA | |
| SCHEMBL25772192 | 0.74 | OXER1 (0.41) | MRGPRX4SMN1; SMN2MAPTLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115203-A1 | OXER1 ANTAGONISTS AND USES THEREOF | FAIRHAVEN PHARMACEUTICALS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |